Company · CIK 0001437786 · SIC 2834 — Pharmaceutical Preparations
IMMUNE DESIGN CORP. · IMDZ
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2019 SForm 4 → | Jan 7, 8:36 pm EST | Carlos V PayaPresident and CEO, Director | 13,014 | $1.58 | $20,591 | 156,576 | −7.67% | plan? |
| Jan 7, 2019 SForm 4 → | Jan 7, 8:35 pm EST | Jan Henrik ter MeulenChief Scientific Officer | 3,414 | $1.59 | $5,415 | 83,982 | −3.91% | plan? |
| Jan 7, 2019 SForm 4 → | Jan 7, 8:34 pm EST | Sergey YurasovSr. VP, Clinic. Devel. & CMO | 3,522 | $1.57 | $5,536 | 78,756 | −4.28% | plan? |
| Jan 7, 2019 SForm 4 → | Jan 7, 8:33 pm EST | Stephen R BradyEVP, Strategy & Finance | 5,516 | $1.58 | $8,722 | 96,599 | −5.40% | plan? |
| Jan 3, 2019 AForm 4 → | Jan 7, 8:36 pm EST | Carlos V PayaPresident and CEO, Director | 63,000 | — | — | 169,590 | — | plan? |
| Jan 3, 2019 AForm 4 → | Jan 7, 8:35 pm EST | Jan Henrik ter MeulenChief Scientific Officer | 25,000 | — | — | 87,396 | — | plan? |
| Jan 3, 2019 AForm 4 → | Jan 7, 8:34 pm EST | Sergey YurasovSr. VP, Clinic. Devel. & CMO | 25,000 | — | — | 82,278 | — | plan? |
| Jan 3, 2019 AForm 4 → | Jan 7, 8:33 pm EST | Stephen R BradyEVP, Strategy & Finance | 25,000 | — | — | 102,115 | — | plan? |
| Dec 4, 2018 SForm 4 → | Dec 4, 9:59 pm EST | BVF PARTNERS L P/IL +610% Owner | 902,000 | $1.83 | $1,653,907 | 370,391 | −70.9% | plan? |
| Nov 7, 2018 AForm 4 → | Nov 9, 4:15 pm EST | Jan Henrik ter MeulenChief Scientific Officer | 23,362 | — | — | 62,396 | — | plan? |
| Nov 7, 2018 AForm 4 → | Nov 9, 4:14 pm EST | Stephen R BradyEVP, Strategy & Finance | 29,953 | — | — | 77,115 | — | plan? |
| Nov 7, 2018 AForm 4 → | Nov 9, 4:13 pm EST | Sergey YurasovSr. VP, Clinic. Devel. & CMO | 29,953 | — | — | 57,278 | — | plan? |
| Jan 8, 2018 PForm 4/A → | Jan 10, 3:00 pm EST | Leo Guthart10% Owner | 20,000 | $3.90 | $78,000 | 5,664,739 | +0.35% | plan? |
| Jan 5, 2018 SForm 4 → | Jan 8, 8:24 pm EST | Wayne GombotzChief Development Officer | 1,986 | $4.17 | $8,282 | 37,068 | −5.09% | plan? |
| Jan 5, 2018 SForm 4 → | Jan 8, 8:21 pm EST | Carlos V PayaPresident and CEO, Director | 7,970 | $4.17 | $33,247 | 106,590 | −6.96% | plan? |
| Jan 5, 2018 SForm 4 → | Jan 8, 8:19 pm EST | Jan Henrik ter MeulenChief Scientific Officer | 1,986 | $4.17 | $8,282 | 39,034 | −4.84% | plan? |
| Jan 5, 2018 SForm 4 → | Jan 8, 8:18 pm EST | Stephen R BradyEVP, Strategy & Finance | 3,328 | $4.17 | $13,885 | 47,162 | −6.59% | plan? |
| Jan 5, 2018 SForm 4/A → | Jan 8, 8:16 pm EST | Sergey YurasovSr. VP, Clinic. Devel. & CMO | 675 | $4.17 | $2,816 | 27,325 | −2.41% | plan? |
| Jan 4, 2018 AForm 4 → | Jan 8, 8:24 pm EST | Wayne GombotzChief Development Officer | 16,000 | — | — | 39,054 | — | plan? |
| Jan 4, 2018 AForm 4 → | Jan 8, 8:21 pm EST | Carlos V PayaPresident and CEO, Director | 46,500 | — | — | 114,560 | — | plan? |
| Jan 4, 2018 AForm 4 → | Jan 8, 8:19 pm EST | Jan Henrik ter MeulenChief Scientific Officer | 18,000 | — | — | 41,020 | — | plan? |
| Jan 4, 2018 AForm 4 → | Jan 8, 8:18 pm EST | Stephen R BradyEVP, Strategy & Finance | 20,000 | — | — | 50,490 | — | plan? |
| Jan 4, 2018 SForm 4 → | Jan 5, 6:30 pm EST | Sergey YurasovSr. VP, Clinic. Devel. & CMO | 675 | $4.17 | $2,816 | 27,325 | −2.41% | plan? |
| Jan 4, 2018 AForm 4 → | Jan 5, 6:30 pm EST | Sergey YurasovSr. VP, Clinic. Devel. & CMO | 22,000 | — | — | 28,000 | — | plan? |
| Nov 2, 2017 PForm 4 → | Nov 6, 9:15 am EST | Lewis W ColemanDirector | 50,000 | $4.50 | $225,000 | 175,000 | +40.0% | plan? |
| Oct 31, 2017 GForm 4/A → | Oct 31, 6:45 pm EDT | Leo Guthart10% Owner | 2,500 | — | — | 5,644,739 | — | plan? |
| Oct 30, 2017 PForm 4 → | Nov 1, 6:10 pm EDT | Franklin M BergerDirector | 25,000 | $4.58 | $114,375 | 75,000 | +50.0% | plan? |
| Oct 27, 2017 PForm 4 → | Oct 31, 7:00 pm EDT | Lewis W ColemanDirector | 65,000 | $4.07 | $264,752 | 125,000 | +108% | plan? |
| Oct 27, 2017 PForm 4/A → | Oct 31, 6:45 pm EDT | Leo Guthart10% Owner | 2,439,000 | $4.10 | $9,999,900 | 5,647,239 | +76.0% | plan? |
| Oct 27, 2017 PForm 4 → | Oct 30, 5:03 pm EDT | COLUMN GROUP L P +710% Owner | 2,681,000 | $4.10 | $10,992,100 | 6,642,942 | +67.7% | plan? |
| Oct 27, 2017 PForm 4 → | Oct 27, 7:40 pm EDT | Peter SvennilsonDirector, 10% Owner | 2,681,000 | $4.10 | $10,992,100 | 2,681,000 | — | plan? |
| Oct 25, 2017 PForm 4 → | Oct 26, 7:31 pm EDT | Franklin M BergerDirector | 25,000 | $4.26 | $106,620 | 50,000 | +100% | plan? |
| Oct 20, 2017 PForm 4/A → | Oct 24, 3:14 pm EDT | Leo Guthart10% Owner | 60,000 | $4.65 | $278,991 | 3,208,239 | +1.91% | plan? |
| Oct 18, 2017 PForm 4/A → | Oct 20, 11:50 am EDT | Leo Guthart10% Owner | 10,000 | $6.09 | $60,938 | 3,148,239 | +0.32% | plan? |
| Sep 18, 2017 PForm 4/A → | Sep 22, 2:47 pm EDT | Leo Guthart10% Owner | 10,000 | $9.70 | $97,000 | 3,138,239 | +0.32% | plan? |
| Aug 1, 2017 SForm 4 → | Aug 3, 5:06 pm EDT | Wayne GombotzChief Development Officer | 10,000 | $11.43 | $114,336 | 23,054 | −30.3% | plan? |
| Aug 1, 2017 MForm 4 → | Aug 3, 5:06 pm EDT | Wayne GombotzChief Development Officer | 10,000 | $1.31 | $13,100 | 33,054 | — | plan? |
| Jul 10, 2017 PForm 4 → | Jul 12, 6:08 pm EDT | Lewis W ColemanDirector | 12,000 | $9.05 | $108,600 | 20,000 | +150% | plan? |
| Jul 6, 2017 PForm 4 → | Jul 10, 7:03 pm EDT | Lewis W ColemanDirector | 8,000 | $9.27 | $74,150 | 8,000 | — | plan? |
| May 9, 2017 PForm 4 → | May 22, 7:40 pm EDT | Leo Guthart10% Owner | 30,000 | $6.09 | $182,607 | 3,128,239 | +0.97% | plan? late |
| Jan 4, 2017 SForm 4 → | Jan 6, 9:36 pm EST | Jan Henrik ter MeulenChief Scientific Officer | 980 | $5.35 | $5,243 | 23,020 | −4.08% | plan? |
| Jan 4, 2017 AForm 4 → | Jan 6, 9:36 pm EST | Jan Henrik ter MeulenChief Scientific Officer | 12,000 | — | — | 24,000 | — | plan? |
| Jan 4, 2017 SForm 4 → | Jan 6, 9:35 pm EST | Wayne GombotzChief Development Officer | 980 | $5.35 | $5,243 | 23,054 | −4.08% | plan? |
| Jan 4, 2017 AForm 4 → | Jan 6, 9:35 pm EST | Wayne GombotzChief Development Officer | 12,000 | — | — | 24,034 | — | plan? |
| Jan 4, 2017 SForm 4 → | Jan 6, 9:32 pm EST | Carlos V PayaPresident and CEO, Director | 3,940 | $5.35 | $21,079 | 68,060 | −5.47% | plan? |
| Jan 4, 2017 AForm 4 → | Jan 6, 9:32 pm EST | Carlos V PayaPresident and CEO, Director | 36,000 | — | — | 72,000 | — | plan? |
| Jan 4, 2017 SForm 4 → | Jan 6, 8:57 pm EST | Stephen R BradyEVP, Strategy & Finance | 1,642 | $5.35 | $8,785 | 30,490 | −5.11% | plan? |
| Jan 4, 2017 AForm 4 → | Jan 6, 8:57 pm EST | Stephen R BradyEVP, Strategy & Finance | 15,000 | — | — | 32,132 | — | plan? |
| Jan 4, 2017 AForm 4 → | Jan 6, 8:51 pm EST | Sergey YurasovSr. VP, Clinic. Devel. & CMO | 6,000 | — | — | 6,000 | — | plan? |
| Dec 22, 2016 SForm 4 → | Dec 27, 8:45 pm EST | Lewis W ColemanDirector | 10,000 | $6.20 | $62,039 | 40,000 | −20.0% | plan? |
| Dec 16, 2016 SForm 4 → | Dec 20, 6:43 pm EST | Franklin M BergerDirector | 50,000 | $6.55 | $327,330 | 25,000 | −66.7% | plan? |
| Sep 20, 2016 PForm 4 → | Sep 22, 2:15 pm EDT | COLUMN GROUP L P +410% Owner | 800,000 | $6.25 | $5,000,000 | 3,961,942 | +25.3% | plan? |
| Sep 20, 2016 PForm 4 → | Sep 20, 8:11 pm EDT | Lewis W ColemanDirector | 40,000 | $6.25 | $250,000 | 50,000 | +400% | plan? |
| Sep 20, 2016 PForm 4 → | Sep 20, 8:10 pm EDT | Peter SvennilsonDirector, 10% Owner | 800,000 | $6.25 | $5,000,000 | 800,000 | — | plan? |
| Jul 15, 2016 PForm 4 → | Jul 19, 5:45 pm EDT | Stephen R BradyEVP, Strategy & Finance | 1,500 | $6.84 | $10,255 | 17,132 | +9.60% | plan? |
| Jan 4, 2016 AForm 4 → | Jan 6, 7:40 pm EST | Jan Henrik ter MeulenChief Scientific Officer | 12,000 | — | — | 12,000 | — | plan? |
| Jan 4, 2016 AForm 4 → | Jan 6, 7:38 pm EST | Carlos V PayaPresident and CEO, Director | 36,000 | — | — | 36,000 | — | plan? |
| Jan 4, 2016 AForm 4 → | Jan 6, 7:36 pm EST | Richard T KenneyChief Medical Officer | 7,000 | — | — | 7,522 | — | plan? |
| Jan 4, 2016 AForm 4 → | Jan 6, 7:34 pm EST | Wayne GombotzChief Development Officer | 12,000 | — | — | 12,034 | — | plan? |
| Jan 4, 2016 AForm 4 → | Jan 6, 7:32 pm EST | Stephen R BradyEVP, Strategy & Finance | 15,000 | — | — | 15,632 | — | plan? |
| Nov 23, 2015 SForm 4 → | Nov 24, 8:01 pm EST | Wayne GombotzChief Development Officer | 5,000 | $20.00 | $100,000 | 34 | −99.3% | plan? |
| Nov 23, 2015 MForm 4 → | Nov 24, 8:01 pm EST | Wayne GombotzChief Development Officer | 5,000 | $1.31 | $6,550 | 5,034 | — | plan? |
| Sep 14, 2015 SForm 4 → | Sep 16, 4:55 pm EDT | Wayne GombotzChief Development Officer | 5,000 | $16.19 | $80,955 | 34 | −99.3% | plan? |
| Sep 14, 2015 MForm 4 → | Sep 16, 4:55 pm EDT | Wayne GombotzChief Development Officer | 5,000 | $1.31 | $6,550 | 5,034 | — | plan? |
| Aug 25, 2015 PForm 4 → | Aug 26, 6:39 pm EDT | Lewis W ColemanDirector | 3,000 | $14.50 | $43,500 | 3,000 | — | plan? |
| May 12, 2015 SForm 4 → | May 13, 9:38 am EDT | ProQuest Investments IV, L.P. +310% Owner | 177,607 | $21.60 | $3,835,732 | 1,983,858 | −8.22% | plan? |
| Apr 22, 2015 SForm 4 → | Apr 24, 4:35 pm EDT | ProQuest Investments IV, L.P. +310% Owner | 82,892 | $26.81 | $2,222,299 | 2,161,465 | −3.69% | plan? |
| Apr 21, 2015 PForm 4 → | Apr 21, 8:10 pm EDT | Lewis W ColemanDirector | 10,000 | $26.50 | $265,000 | 10,000 | — | plan? |
| Apr 21, 2015 PForm 4 → | Apr 21, 8:08 pm EDT | Franklin M BergerDirector | 25,000 | $26.50 | $662,500 | 75,000 | +50.0% | plan? |
| Apr 17, 2015 SForm 4 → | Apr 21, 4:55 pm EDT | ProQuest Investments IV, L.P. +310% Owner | 45,820 | $26.51 | $1,214,544 | 2,244,357 | −2.00% | plan? |
| Apr 14, 2015 SForm 4 → | Apr 16, 4:33 pm EDT | ProQuest Investments IV, L.P. +310% Owner | 53,914 | $28.23 | $1,522,105 | 2,290,177 | −2.30% | plan? |
| Apr 6, 2015 SForm 4 → | Apr 8, 2:45 pm EDT | ProQuest Investments IV, L.P. +310% Owner | 7,495 | $26.72 | $200,278 | 2,344,091 | −0.32% | plan? |
| Apr 1, 2015 SForm 4 → | Apr 2, 11:00 am EDT | ProQuest Investments IV, L.P. +310% Owner | 62,454 | $26.37 | $1,647,148 | 2,351,586 | −2.59% | plan? |
| Mar 24, 2015 SForm 4 → | Mar 26, 4:52 pm EDT | ProQuest Investments IV, L.P. +310% Owner | 18,156 | $27.64 | $501,831 | 2,414,040 | −0.75% | plan? |
| Mar 19, 2015 SForm 4 → | Mar 23, 5:10 pm EDT | ProQuest Investments IV, L.P. +310% Owner | 44,464 | $27.52 | $1,223,478 | 2,432,196 | −1.80% | plan? |
| Mar 16, 2015 SForm 4 → | Mar 18, 4:57 pm EDT | ProQuest Investments IV, L.P. +310% Owner | 50,309 | $26.09 | $1,312,467 | 2,476,660 | −1.99% | plan? |
| Mar 10, 2015 SForm 4 → | Mar 12, 4:11 pm EDT | ProQuest Investments IV, L.P. +310% Owner | 129,342 | $24.94 | $3,226,328 | 2,526,969 | −4.87% | plan? |
| Mar 5, 2015 SForm 4 → | Mar 9, 5:10 pm EDT | ProQuest Investments IV, L.P. +310% Owner | 39,446 | $25.45 | $1,003,755 | 2,656,311 | −1.46% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2019 AForm 4 → | Jan 7, 8:36 pm EST | Carlos V PayaPresident and CEO, Director | 293,000 | — | — | 293,000 | — | |
| Jan 3, 2019 AForm 4 → | Jan 7, 8:35 pm EST | Jan Henrik ter MeulenChief Scientific Officer | 120,000 | — | — | 120,000 | — | |
| Jan 3, 2019 AForm 4 → | Jan 7, 8:34 pm EST | Sergey YurasovSr. VP, Clinic. Devel. & CMO | 110,000 | — | — | 110,000 | — | |
| Jan 3, 2019 AForm 4 → | Jan 7, 8:33 pm EST | Stephen R BradyEVP, Strategy & Finance | 120,000 | — | — | 120,000 | — | |
| Jan 3, 2019 AForm 4 → | Jan 7, 8:19 pm EST | Lewis W ColemanDirector | 12,500 | — | — | 12,500 | — | |
| Jan 3, 2019 AForm 4 → | Jan 7, 8:18 pm EST | William R RingoDirector | 12,500 | — | — | 12,500 | — | |
| Jan 3, 2019 AForm 4 → | Jan 7, 8:17 pm EST | Franklin M BergerDirector | 12,500 | — | — | 12,500 | — | |
| Jan 3, 2019 AForm 4 → | Jan 7, 8:16 pm EST | David BaltimoreDirector | 12,500 | — | — | 12,500 | — | |
| Jan 3, 2019 AForm 4 → | Jan 7, 8:15 pm EST | Susan L. KelleyDirector | 12,500 | — | — | 12,500 | — | |
| Jan 3, 2019 AForm 4 → | Jan 7, 8:14 pm EST | Edward PenhoetDirector | 12,500 | — | — | 12,500 | — | |
| Jul 17, 2018 ADForm 4 → | Jul 19, 6:06 pm EDT | Stephen R BradyEVP, Strategy & Finance | 484,119 | — | — | 47,190 | — | |
| Jul 17, 2018 ADForm 4 → | Jul 19, 6:05 pm EDT | Carlos V PayaPresident and CEO, Director | 707,519 | — | — | 96,874 | — | |
| Jul 17, 2018 ADForm 4 → | Jul 19, 6:03 pm EDT | Wayne GombotzChief Development Officer | 183,454 | — | — | 30,911 | — | |
| Jul 17, 2018 ADForm 4 → | Jul 19, 6:02 pm EDT | Jan Henrik ter MeulenChief Scientific Officer | 131,788 | — | — | 31,101 | — | |
| Jul 17, 2018 ADForm 4 → | Jul 19, 6:01 pm EDT | Sergey YurasovSr. VP, Clinic. Devel. & CMO | 283,335 | — | — | 19,584 | — | |
| Jan 4, 2018 AForm 4 → | Jan 8, 8:33 pm EST | Susan L. KelleyDirector | 12,500 | — | — | 12,500 | — | |
| Jan 4, 2018 AForm 4 → | Jan 8, 8:32 pm EST | Franklin M BergerDirector | 12,500 | — | — | 12,500 | — | |
| Jan 4, 2018 AForm 4 → | Jan 8, 8:31 pm EST | William R RingoDirector | 12,500 | — | — | 12,500 | — | |
| Jan 4, 2018 AForm 4 → | Jan 8, 8:30 pm EST | Lewis W ColemanDirector | 12,500 | — | — | 12,500 | — | |
| Jan 4, 2018 AForm 4 → | Jan 8, 8:28 pm EST | Edward PenhoetDirector | 12,500 | — | — | 12,500 | — | |
| Jan 4, 2018 AForm 4 → | Jan 8, 8:27 pm EST | Peter SvennilsonDirector, 10% Owner | 12,500 | — | — | 12,500 | — | |
| Jan 4, 2018 AForm 4 → | Jan 8, 8:26 pm EST | David BaltimoreDirector | 12,500 | — | — | 12,500 | — | |
| Jan 4, 2018 AForm 4 → | Jan 8, 8:24 pm EST | Wayne GombotzChief Development Officer | 80,000 | — | — | 80,000 | — | |
| Jan 4, 2018 AForm 4 → | Jan 8, 8:21 pm EST | Carlos V PayaPresident and CEO, Director | 216,500 | — | — | 216,500 | — | |
| Jan 4, 2018 AForm 4 → | Jan 8, 8:19 pm EST | Jan Henrik ter MeulenChief Scientific Officer | 90,000 | — | — | 90,000 | — | |
| Jan 4, 2018 AForm 4 → | Jan 8, 8:18 pm EST | Stephen R BradyEVP, Strategy & Finance | 100,000 | — | — | 100,000 | — | |
| Jan 4, 2018 AForm 4 → | Jan 5, 6:30 pm EST | Sergey YurasovSr. VP, Clinic. Devel. & CMO | 110,000 | — | — | 110,000 | — | |
| Aug 1, 2017 MForm 4 → | Aug 3, 5:06 pm EDT | Wayne GombotzChief Development Officer | 10,000 | — | — | 38,715 | — | |
| Jan 4, 2017 AForm 4 → | Jan 6, 9:47 pm EST | William R RingoDirector | 10,000 | — | — | 10,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 6, 9:36 pm EST | Jan Henrik ter MeulenChief Scientific Officer | 70,000 | — | — | 70,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 6, 9:35 pm EST | Wayne GombotzChief Development Officer | 70,000 | — | — | 70,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 6, 9:32 pm EST | Carlos V PayaPresident and CEO, Director | 175,000 | — | — | 175,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 6, 9:07 pm EST | David BaltimoreDirector | 10,000 | — | — | 10,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 6, 9:05 pm EST | Edward PenhoetDirector | 10,000 | — | — | 10,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 6, 9:04 pm EST | Susan L. KelleyDirector | 10,000 | — | — | 10,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 6, 9:03 pm EST | Peter SvennilsonDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 6, 9:00 pm EST | Lewis W ColemanDirector | 10,000 | — | — | 10,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 6, 8:57 pm EST | Stephen R BradyEVP, Strategy & Finance | 85,000 | — | — | 85,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 6, 8:51 pm EST | Sergey YurasovSr. VP, Clinic. Devel. & CMO | 30,000 | — | — | 30,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 6, 8:47 pm EST | Franklin M BergerDirector | 10,000 | — | — | 10,000 | — | |
| Oct 1, 2016 AForm 4 → | Oct 4, 4:35 pm EDT | Sergey YurasovSr. VP, Clinic. Devel. & CMO | 140,000 | — | — | 140,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 17, 1:41 pm EDT | Susan L. KelleyDirector | 23,300 | — | — | 23,300 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 7:40 pm EST | Jan Henrik ter MeulenChief Scientific Officer | 60,000 | — | — | 60,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 7:38 pm EST | Carlos V PayaPresident and CEO, Director | 175,000 | — | — | 175,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 7:36 pm EST | Richard T KenneyChief Medical Officer | 30,000 | — | — | 30,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 7:34 pm EST | Wayne GombotzChief Development Officer | 60,000 | — | — | 60,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 7:32 pm EST | Stephen R BradyEVP, Strategy & Finance | 75,000 | — | — | 75,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 7:30 pm EST | William R RingoDirector | 9,300 | — | — | 9,300 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 7:28 pm EST | Peter SvennilsonDirector | 9,300 | — | — | 9,300 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 7:25 pm EST | Edward PenhoetDirector | 9,300 | — | — | 9,300 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 7:08 pm EST | Lewis W ColemanDirector | 9,300 | — | — | 9,300 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 7:06 pm EST | Franklin M BergerDirector | 9,300 | — | — | 9,300 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 7:04 pm EST | David BaltimoreDirector | 9,300 | — | — | 9,300 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 7:03 pm EST | Brian G AtwoodDirector | 9,300 | — | — | 9,300 | — | |
| Nov 23, 2015 MForm 4 → | Nov 24, 8:01 pm EST | Wayne GombotzChief Development Officer | 5,000 | — | — | 48,715 | — | |
| Oct 30, 2015 AForm 4 → | Nov 3, 5:53 pm EST | Wayne GombotzChief Development Officer | 40,000 | — | — | 40,000 | — | |
| Oct 30, 2015 AForm 4 → | Nov 3, 5:50 pm EST | Jan Henrik ter MeulenChief Scientific Officer | 40,000 | — | — | 40,000 | — | |
| Oct 30, 2015 AForm 4 → | Nov 3, 5:45 pm EST | Richard T KenneyChief Medical Officer | 40,000 | — | — | 40,000 | — | |
| Oct 30, 2015 AForm 4 → | Nov 3, 5:43 pm EST | Stephen R BradyEVP, Strategy & Finance | 50,000 | — | — | 50,000 | — | |
| Oct 30, 2015 AForm 4 → | Nov 3, 5:41 pm EST | Carlos V PayaPresident and CEO, Director | 90,000 | — | — | 90,000 | — | |
| Sep 14, 2015 MForm 4 → | Sep 16, 4:55 pm EDT | Wayne GombotzChief Development Officer | 5,000 | — | — | 53,715 | — | |
| Mar 18, 2015 AForm 4 → | Mar 19, 7:40 pm EDT | Lewis W ColemanDirector | 23,300 | — | — | 23,300 | — | |
| Jan 7, 2015 AForm 4 → | Jan 9, 4:29 pm EST | Jan Henrik ter MeulenChief Scientific Officer | 25,000 | — | — | 25,000 | — | |
| Jan 7, 2015 AForm 4 → | Jan 9, 4:28 pm EST | Richard T KenneyChief Medical Officer | 30,000 | — | — | 30,000 | — | |
| Jan 7, 2015 AForm 4 → | Jan 9, 4:26 pm EST | David BaltimoreDirector | 9,300 | — | — | 9,300 | — | |
| Jan 7, 2015 AForm 4 → | Jan 9, 4:25 pm EST | Franklin M BergerDirector | 9,300 | — | — | 9,300 | — | |
| Jan 7, 2015 AForm 4 → | Jan 9, 4:24 pm EST | Wayne GombotzChief Development Officer | 15,000 | — | — | 15,000 | — | |
| Jan 7, 2015 AForm 4 → | Jan 9, 4:23 pm EST | Brian G AtwoodDirector | 9,300 | — | — | 9,300 | — | |
| Jan 7, 2015 AForm 4 → | Jan 9, 4:22 pm EST | Edward PenhoetDirector | 9,300 | — | — | 9,300 | — | |
| Jan 7, 2015 AForm 4 → | Jan 9, 4:20 pm EST | Stephen R BradyChief Business Officer | 50,000 | — | — | 50,000 | — | |
| Jan 7, 2015 AForm 4 → | Jan 9, 4:18 pm EST | Peter SvennilsonDirector | 9,300 | — | — | 9,300 | — | |
| Jan 7, 2015 AForm 4 → | Jan 9, 4:17 pm EST | William R RingoDirector | 9,300 | — | — | 9,300 | — | |
| Jan 7, 2015 AForm 4 → | Jan 9, 4:16 pm EST | James Paul RickeyVP, Finance and Administration | 25,000 | — | — | 25,000 | — | |
| Jan 7, 2015 AForm 4 → | Jan 9, 4:14 pm EST | Carlos V PayaPresident and CEO, Director | 100,000 | — | — | 100,000 | — |